Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rui-Qin Liu

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Bioorganic & Medicinal Chemistry Letters|February 5, 2003
Both 5-arylidene-2-thioxodihydropyrimidine-4,6(1H,5H)-diones and 3-thioxo-2,3-dihydro-1H-imidazo[1,5-a]indol-1-ones are light-dependent tumor necrosis factor-alpha antagonistsMatthew E Voss, Percy H Carter, Andrew J Tebben, et al.
Bioorganic & Medicinal Chemistry Letters|March 7, 2006
Synthesis and structure-activity relationship of a novel, achiral series of TNF-alpha converting enzyme inhibitorsJohn L Gilmore, Bryan W King, Cathy Harris, et al.
Bioorganic & Medicinal Chemistry Letters|September 11, 2004
Synthesis and structure-activity relationship of a novel sulfone series of TNF-alpha converting enzyme inhibitorsChu-Biao Xue, Xiao-Tao Chen, Xiaohua He, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 28, 2007
Pharmacokinetics and pharmacodynamics of DPC 333 ((2R)-2-((3R)-3-amino-3{4-[2-methyl-4-quinolinyl) methoxy] phenyl}-2-oxopyrrolidinyl)-N-hydroxy-4-methylpentanamide)), a potent and selective inhibitor of tumor necrosis factor alpha-converting enzyme in rodents, dogs, chimpanzees, and humansMingxin Qian, Stephen A Bai, Bernice Brogdon, et al.
Bioorganic & Medicinal Chemistry Letters|March 27, 2003
Potent and selective aggrecanase inhibitors containing cyclic P1 substituentsRobert J Cherney, Ruowei Mo, Dayton T Meyer, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 13, 2007
Discovery of a small molecule antagonist of the parathyroid hormone receptor by using an N-terminal parathyroid hormone peptide probePercy H Carter, Rui-Qin Liu, William R Foster, et al.
Bioorganic & Medicinal Chemistry Letters|December 3, 2003
Rational design, synthesis and structure-activity relationships of a cyclic succinate series of TNF-alpha converting enzyme inhibitors. Part 2: lead optimizationChu-Biao Xue, Xiaohua He, John Roderick, et al.
Bioorganic & Medicinal Chemistry Letters|February 6, 2007
A new 4-(2-methylquinolin-4-ylmethyl)phenyl P1' group for the beta-amino hydroxamic acid derived TACE inhibitorsXiao-Tao Chen, Bahman Ghavimi, Ronald L Corbett, et al.
Bioorganic & Medicinal Chemistry Letters|February 14, 2006
Synthesis and evaluation of succinoyl-caprolactam gamma-secretase inhibitorsLorin A Thompson, Ann Y Liauw, Mercy M Ramanjulu, et al.
Journal of Medicinal Chemistry|May 2, 2003
Design, synthesis, and evaluation of benzothiadiazepine hydroxamates as selective tumor necrosis factor-alpha converting enzyme inhibitorsRobert J Cherney, James J-W Duan, Matthew E Voss, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Bioorganic & Medicinal Chemistry Letters|February 5, 2003
Both 5-arylidene-2-thioxodihydropyrimidine-4,6(1H,5H)-diones and 3-thioxo-2,3-dihydro-1H-imidazo[1,5-a]indol-1-ones are light-dependent tumor necrosis factor-alpha antagonistsMatthew E Voss, Percy H Carter, Andrew J Tebben, et al.
Bioorganic & Medicinal Chemistry Letters|March 7, 2006
Synthesis and structure-activity relationship of a novel, achiral series of TNF-alpha converting enzyme inhibitorsJohn L Gilmore, Bryan W King, Cathy Harris, et al.
Bioorganic & Medicinal Chemistry Letters|September 11, 2004
Synthesis and structure-activity relationship of a novel sulfone series of TNF-alpha converting enzyme inhibitorsChu-Biao Xue, Xiao-Tao Chen, Xiaohua He, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 28, 2007
Pharmacokinetics and pharmacodynamics of DPC 333 ((2R)-2-((3R)-3-amino-3{4-[2-methyl-4-quinolinyl) methoxy] phenyl}-2-oxopyrrolidinyl)-N-hydroxy-4-methylpentanamide)), a potent and selective inhibitor of tumor necrosis factor alpha-converting enzyme in rodents, dogs, chimpanzees, and humansMingxin Qian, Stephen A Bai, Bernice Brogdon, et al.
Bioorganic & Medicinal Chemistry Letters|March 27, 2003
Potent and selective aggrecanase inhibitors containing cyclic P1 substituentsRobert J Cherney, Ruowei Mo, Dayton T Meyer, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 13, 2007
Discovery of a small molecule antagonist of the parathyroid hormone receptor by using an N-terminal parathyroid hormone peptide probePercy H Carter, Rui-Qin Liu, William R Foster, et al.
Bioorganic & Medicinal Chemistry Letters|December 3, 2003
Rational design, synthesis and structure-activity relationships of a cyclic succinate series of TNF-alpha converting enzyme inhibitors. Part 2: lead optimizationChu-Biao Xue, Xiaohua He, John Roderick, et al.
Bioorganic & Medicinal Chemistry Letters|February 6, 2007
A new 4-(2-methylquinolin-4-ylmethyl)phenyl P1' group for the beta-amino hydroxamic acid derived TACE inhibitorsXiao-Tao Chen, Bahman Ghavimi, Ronald L Corbett, et al.
Bioorganic & Medicinal Chemistry Letters|February 14, 2006
Synthesis and evaluation of succinoyl-caprolactam gamma-secretase inhibitorsLorin A Thompson, Ann Y Liauw, Mercy M Ramanjulu, et al.
Journal of Medicinal Chemistry|May 2, 2003
Design, synthesis, and evaluation of benzothiadiazepine hydroxamates as selective tumor necrosis factor-alpha converting enzyme inhibitorsRobert J Cherney, James J-W Duan, Matthew E Voss, et al.
Pageof 4